Table 5.
Serum concentration of interleukin-27 (IL-27) by the time interval from blood collection to diagnosis of hepatocellular carcinoma, The Singapore Chinese Health Study and The Shanghai Cohort Study separately and combined
Time interval (yr) | Singapore Cohort Study | Shanghai Cohort Study | Both Cohort Studies combined | |||||
---|---|---|---|---|---|---|---|---|
N | IL-27 (ng/ml)a | N | IL-27a | N | IL-27 (ng/ml)a | |||
0.3–<3 | 29 | 2.86 (2.36–3.46) | 37 | 3.32 (2.66–4.12) | 66 | 3.22 (2.78–3.72) | ||
3–<6 | 41 | 2.12 (1.80–2.50) | 26 | 2.60 (2.02–3.36) | 67 | 2.40 (2.08–2.76) | ||
6–10 | 30 | 2.20 (1.82–2.66) | 37 | 2.44 (1.96–3.02) | 67 | 2.26 (1.94–2.62) | ||
P trend | 0.072 | 0.062 | 0.001 |
Geometric means were derived from analysis of covariance with following covariates: study location (Shanghai vs Singapore), sex, body mass index (<18.5, 18-<23, 23-<27.5, ≥27.5 kg/m2), alcohol consumption (nondrinkers, moderate drinkers, and heavy drinkers), and cigarette smoking (never, former, current smokers), and serological status of hepatitis B surface antigen or antibodies to hepatitis C virus (negative, positive).